Upper Arm Blood pressure monitor (BP7155D)
OMRON Healthcare, Inc. · Decision date Sep 10, 2026
What did the FDA decide?
FDA recorded a substantially equivalent (SESE) decision on September 10, 2026 for K261929, an upper arm blood pressure monitor submitted by OMRON Healthcare, Inc. of Hoffman Estates, Illinois. The device is listed as the Upper Arm Blood pressure monitor (BP7155D) under regulation number 870.1130, product code DXN, in the Cardiovascular specialty; the application was received June 9, 2026. SESE in a 510(k) pathway denotes clearance to market, not premarket approval of the device.
The FDA review document describes the Omron BP7155D as a battery-powered, non-invasive upper arm monitor intended for over-the-counter home use, measuring systolic pressure, and states that the proposed device incorporates Bluetooth Low Energy to transmit stored blood pressure and pulse data to external devices. The record does not include the full intended-use statement, measurement ranges or accuracy data, so performance characteristics remain unknown from this source.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Cardiovascular
- Decision date
- Sep 10, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K261929
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- OMRON Healthcare, Inc.
- Product code
- DXN
- Decision code
- SESE
- Decision date
- Sep 10, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: System, Measurement, Blood-Pressure, Non-Invasive.
- Applicant
- OMRON Healthcare, Inc.
- Product code
- DXN
- FDA device class
- 2
FDA decision timeline
K261929 received
Application receipt date recorded by FDA.
K261929 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code DXN
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. | 510(k) clearance | Oct 28, 2026 | FDA | |
| Shenzhen Brav Electronic Technologies Co., Ltd. | 510(k) clearance | Oct 1, 2026 | FDA | |
| Happy Health, Inc. | 510(k) clearance | Sep 3, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
OMRON Healthcare, Inc.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Hoffman Estates, IL
Sources and methodology
- Original FDA record: K261929
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records

